Psychiatry and Neurology, Neurology · Asheville, NC
NPI
1518945690
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
731 Dogwood Road
Asheville, NC, 28806
Phone (828) 210-9300
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
113,014 services
Medicare patients, 2024
914
Average age 73
Drug cost, 2024
$1.9M
7,217 prescriptions
Company payments, 2025
$2,534
From 46 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James M Patton was code J0585 (injection, onabotulinumtoxina, 1 unit), 64,602 times for 103 patients. In total James M Patton billed 113,014 services in 64 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 64,602 | 103 | $4.90 | $317K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 14,850 | 37 | $4.02 | $60K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 599 | 450 | $11.09 | $6,641 |
| 99214 Office E&M - Established | Office | 508 | 400 | $81.35 | $41K |
| 95874 Musculoskeletal | Office | 327 | 110 | $52.45 | $17K |
| 99213 Office E&M - Established | Office | 233 | 208 | $54.82 | $13K |
| 64616 Musculoskeletal | Office | 204 | 63 | $109.57 | $22K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 175 | 63 | $46.93 | $8,213 |
| 99204 Office E&M - New | Office | 111 | 111 | $93.45 | $10K |
| 64612 Musculoskeletal | Office | 100 | 33 | $122.52 | $12K |
| 64642 Musculoskeletal | Office | 92 | 34 | $94.26 | $8,672 |
| 64643 Musculoskeletal | Office | 91 | 22 | $63.40 | $5,769 |
| 99215 Office E&M - Established | Office | 85 | 72 | $112.10 | $9,529 |
| 96413 Chemotherapy Administration | Office | 70 | 25 | $90.96 | $6,367 |
| 96375 Injection Administration | Office | 49 | 12 | $11.31 | $554 |
By year: 2022 $1.2M for 113,236 services; 2023 $1.1M for 121,021 services; 2024 $1.3M for 113,014 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 45 | 43 | $8.46 | $381 |
Medicare prescription drug claims, 2024
In 2024, the drug James M Patton prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 922 prescriptions and refills. In total James M Patton wrote 7,217 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 922 | 1,947 | 275 | $30K |
| Gabapentin Generic | 483 | 813 | 136 | $9,667 |
| Baclofen Generic | 299 | 490 | 74 | $6,912 |
| Tizanidine Hcl Generic | 258 | 453 | 71 | $7,457 |
| Donepezil Hcl Generic | 254 | 418 | 70 | $2,264 |
| Clonazepam Generic | 249 | 277 | 53 | $1,971 |
| Primidone Generic | 245 | 534 | 77 | $7,336 |
| Propranolol Hcl Generic | 199 | 403 | 66 | $1,794 |
| Botox Onabotulinumtoxina | 175 | 490 | 61 | $230K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 153 | 295 | 48 | $9,518 |
| Topiramate Generic | 135 | 293 | 45 | $1,365 |
| Trazodone Hcl Generic | 124 | 253 | 40 | $980 |
| Duloxetine Hcl Generic | 119 | 205 | 30 | $2,373 |
| Cyclobenzaprine Hcl Generic | 113 | 122 | 26 | $974 |
| Diazepam Generic | 106 | 108 | 21 | $679 |
Brand drugs: 745 claims; generic drugs: 6,472 claims; opioid claims: 189.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James M Patton $2,534 ($2,534 in general payments such as food, travel and fees) from 46 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $340.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 11 | $340 |
| Abbvie Inc. ABBV | 56 | $314 |
| Biogen, Inc. BIIB | 9 | $162 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $101 |
| Neurelis, Inc. | 2 | $85.49 |
| MDD US Operations, LLC | 3 | $70.36 |
| Cycle Pharmaceuticals Inc | 3 | $67.49 |
| ACADIA Pharmaceuticals Inc ACAD | 2 | $65.01 |
| Pfizer Inc. PFE | 3 | $64.27 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $64.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.